keyword
https://read.qxmd.com/read/38710017/the-degree-of-hla-matching-determines-the-incidence-of-cytokine-release-syndrome-and-associated-nonrelapse-mortality-in-matched-related-and-unrelated-allogeneic-stem-cell-transplantation-with-post-transplant-cyclophosphamide
#21
JOURNAL ARTICLE
Peter A von dem Borne, Berit M Kemps-Mols, Liesbeth C de Wreede, Adriaan A van Beek, Tjeerd J F Snijders, Daniëlle van Lammeren, Janneke Tijmensen, Aniko Sijs-Szabó, Mirjam A Oudshoorn, Constantijn J M Halkes, Peter van Balen, W A Erik Marijt, Jennifer M L Tjon, Joost S P Vermaat, Hendrik Veelken
Cytokine release syndrome (CRS) occurs frequently after haplo-identical allogeneic stem cell transplantation (alloSCT) with post-transplant cyclophosphamide (PTCy), increasing nonrelapse mortality (NRM) and decreasing survival. Data on CRS in HLA-matched alloSCT are limited and effects of specific HLA-mismatches on CRS development unknown. We hypothesized that in HLA-matched alloSCT increasing degrees of HLA-mismatching influence CRS incidence, NRM and survival. Retrospective analysis of 126 HLA-matched PTCy-alloSCT patients showed that higher degrees of HLA-mismatching significantly increased CRS incidence (26%, 75% and 90% CRS with 12/12, 10/10 and 9/10 matched donors, respectively)...
May 6, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38708102/ameliorative-effect-of-total-ginsenosides-from-heat-treated-fresh-ginseng-against-cyclophosphamide-induced-liver-injury-in-mice
#22
JOURNAL ARTICLE
Ping Tang, Guangquan Ren, Hongyang Zou, Sitong Liu, Junshun Zhang, Zhiyi Ai, Yue Hu, Linlin Cui, Bo Nan, Zhicheng Zhang, Yuhua Wang
This study evaluated the effect of heat treatment on the conversion of ginsenoside and the ameliorative effect of heat-treated total ginsenoside (HG) from fresh ginseng on cyclophosphamide (CTX)-induced liver injury. LC-MS analysis revealed that the content of rare ginsenosides increased markedly after heat treatment. HG significantly attenuated CTX-induced hepatic histopathological injury in mice. Western blotting analysis showed that untreated total ginsenoside (UG) and HG regulated the Nrf2/HO-1 and TLR4/MAPK pathways...
2024: Current research in food science
https://read.qxmd.com/read/38707835/predictive-factors-of-renal-recovery-and-progression-to-end-stage-kidney-disease-in-patients-with-antineutrophil-cytoplasmic-autoantibody-associated-vasculitis-with-severe-kidney-disease
#23
JOURNAL ARTICLE
Marta Casal Moura, Dalia Zubidat, Marc Patricio Liebana, Sanjeev Sethi, Maria Jose Soler, Ladan Zand, Fernanda G Dos Santos, Luca Nardelli, Juan Leon-Roman, Ciria Sousa, Kenneth J Warrington, Ulrich Specks, Fernando C Fervenza
INTRODUCTION: A significant number of patients with antineutrophil cytoplasmic antibodies (ANCA)- associated vasculitis (AAV) with glomerulonephritis (AAV-GN) still progress to end-stage kidney disease (ESKD, estimated glomerular filtration rate [eGFR] <15 ml/min per 1.73 m2 ) despite advances in remission-induction treatment. METHODS: This is a retrospective cohort study on myeloperoxidase (MPO)-ANCA or proteinase 3 (PR3)-ANCA positive patients with AAV (microscopic polyangiitis, MPA; or granulomatosis with polyangiitis, GPA) and eGFR <15 ml/min per 1...
May 2024: KI Reports
https://read.qxmd.com/read/38707806/clinical-characteristics-and-outcomes-of-neural-epidermal-growth-factor-like-1-protein-associated-membranous-nephropathy
#24
JOURNAL ARTICLE
Suruthy Narayanasami, Niranjan Anitha Vijayakumar, Mayuri Trivedi, Aravind Sekar, Shabna Sulaiman, Saurabh Nayak, Neeraj Inamdar, Sourabh Sharma, Rajeevalochana Parthasarathy, Vidya Kadam, Vaibhav Keskar, Sahil Bagai, Ashwani Kumar, Bajinder Reen, Anila Abraham Kurien, Alok Sharma, Dinesh Khullar, Benil Hafeeq, Arvind Krishnakumar, Shafeeque Rahman Kv, Ismail Na, Sanjeev Nair, Smita Divyaveer, Manish Rathi, Harbir Singh Kohli, Ritambhra Nada, Raja Ramachandran
No abstract text is available yet for this article.
May 2024: KI Reports
https://read.qxmd.com/read/38707773/extramedullary-plasmacytoma-of-the-orbit-complicating-the-evolution-of-multiple-myeloma-in-complete-remission
#25
Nader Slama, Inaam Bizid, Ahlem Bellalah, Mabrouk Abdelali, Mohamed Adnene Laatiri
Orbital plasmacytoma is rare and has only been reported in the context of the initial diagnosis of multiple myeloma. Moreover, isolated orbital plasmacytoma without any signs of multiple myeloma is extremely rare. We report the case of a 59-year-old female patient diagnosed with IgA Kappa multiple myeloma. It was stage I ISS (International Staging System) and stage I R-ISS (Revised ISS). According to the Tunisian national protocol, the patient was included in the standard-risk group and was eligible for four cycles of CTD (Cyclophosphamide, Thalidomide, Dexamethasone) followed by autologous stem cell transplantation...
2024: Leukemia Research Reports
https://read.qxmd.com/read/38707732/pleomorphic-rhabdomyosarcoma-of-the-uterine-corpus-in-an-adult-who-underwent-multi-gene-panel-testing
#26
JOURNAL ARTICLE
Tamami Odai, Noriko Oshima, Yusuke Kori, Maki Takao, Kimio Wakana, Naoyuki Miyasaka
BACKGROUND/AIM: Rhabdomyosarcoma (RMS) is the most common malignant soft tissue tumor in children. Adult primary RMS of gynecological origin is a rare condition and uterine RMS is an aggressive malignancy with a poor prognosis. The genetic variants associated with uterine RMS in adults have yet to be fully elucidated, and there is no established therapeutic strategy for rare tumors. CASE REPORT: A 69-year-old Japanese woman was referred to our hospital with abdominal bloating...
2024: Cancer Diagn Progn
https://read.qxmd.com/read/38707639/gintonin-upregulates-cytokine-production-and-expression-of-nkp30-nkp44-and-nkp44-related-to-natural-killer-cell-activity-on-immunosuppressive-rat
#27
JOURNAL ARTICLE
BaiCheng Chen, Ajay Vijayakumar, Chul Park, Ulsoo Choi, Seung-Yeol Nah, Jong-Hoon Kim
The objective of the study is to estimate the potential of gintonin, as an immune enhancing agent through natural killer cell (NK cell) activity in cyclophosphamide (CY)-induced immunosuppressive animals. Accumulated results reveals that, gintonin attenuated CY-induced immunosuppression and it might modulate NK cell activity to boost the immunity.
May 2024: Journal of Ginseng Research
https://read.qxmd.com/read/38707080/diffuse-interstitial-lung-disease-revealing-antisynthetase-syndrome
#28
Hanane Benjelloun, Fatima Ezzahra Haouassia, Khadija Chaanoune, Nahid Zaghba, Najiba Yassine
Interstitial lung disease (ILD) is a frequent manifestation of connective tissue diseases. They may be revelatory of the disease or occur during follow-up. Antisynthetase syndrome (ASS) is a complex and heterogeneous autoimmune disorder. Antisynthetase antibodies, in particular the anti-Jo-1 antibody, characterize this syndrome. The occurrence and severity of ILD determine the prognosis, which in turn determines therapeutic management. We report the case of a 53-year-old female patient presenting with ILD, revealing the diagnosis of ASS...
April 2024: Curēus
https://read.qxmd.com/read/38705428/lc-qtof-ms-ms-phytochemical-profiling-of-tabebuia-impetiginosa-mart-ex-dc-standl-leaf-and-assessment-of-its-neuroprotective-potential-in-rats
#29
JOURNAL ARTICLE
Nesma Khaled, Nehal Ibrahim, Alaa E Ali, Fadia S Youssef, Sherweit H El-Ahmady
ETHNOPHARMACOLOGICAL RELEVANCE: Tabebuia impetiginosa (Bignoniaceae) was traditionally used for memory enhancement and central nervous system (CNS) stimulation. AIM OF THE STUDY: This study aims to create a metabolic profile of the ethyl acetate fraction of T. impetiginosa (TEF) and investigate for the first time its neuroprotective potential on cyclophosphamide (CP)-induced chemobrain, validating its traditional use. MATERIALS AND METHODS: Metabolite profiling of TEF was performed using Liquid Chromatography coupled with Quadrupole Time of Flight-Mass/Mass Spectrometry (LC-qTOF-MS/M)...
May 3, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38705160/ibrutinib-combined-with-immunochemotherapy-with-or-without-autologous-stem-cell-transplantation-versus-immunochemotherapy-and-autologous-stem-cell-transplantation-in-previously-untreated-patients-with-mantle-cell-lymphoma-triangle-a-three-arm-randomised-open
#30
JOURNAL ARTICLE
Martin Dreyling, Jeanette Doorduijn, Eva Giné, Mats Jerkeman, Jan Walewski, Martin Hutchings, Ulrich Mey, Jon Riise, Marek Trneny, Vibeke Vergote, Ofer Shpilberg, Maria Gomes da Silva, Sirpa Leppä, Linmiao Jiang, Stephan Stilgenbauer, Andrea Kerkhoff, Ron D Jachimowicz, Melania Celli, Georg Hess, Luca Arcaini, Carlo Visco, Tom van Meerten, Stefan Wirths, Pier Luigi Zinzani, Urban Novak, Peter Herhaus, Fabio Benedetti, Kristina Sonnevi, Christine Hanoun, Matthias Hänel, Judith Dierlamm, Christiane Pott, Wolfram Klapper, Döndü Gözel, Christian Schmidt, Michael Unterhalt, Marco Ladetto, Eva Hoster
BACKGROUND: Adding ibrutinib to standard immunochemotherapy might improve outcomes and challenge autologous stem-cell transplantation (ASCT) in younger (aged 65 years or younger) mantle cell lymphoma patients. This trial aimed to investigate whether the addition of ibrutinib results in a superior clinical outcome compared with the pre-trial immunochemotherapy standard with ASCT or an ibrutinib-containing treatment without ASCT. We also investigated whether standard treatment with ASCT is superior to a treatment adding ibrutinib but without ASCT...
May 2, 2024: Lancet
https://read.qxmd.com/read/38701734/evaluation-of-some-proinflammatory-cytokines-and-biochemical-parameters-in-pre-and-postmenopausal-breast-cancer-women
#31
JOURNAL ARTICLE
Maryam Mohammed Bakheet, Hiba Mohssin Ali, Tabarak Jalil Talab
The study was planned to evaluate the differences in certain proinflammatory cytokines(IL-6, TNF-α) with CRP and biochemical parameters (E2, D3, LDH, GGT, TSB, Ca, Ph, uric acid), between women with pre- and postmenopausal breast cancer and seemingly healthy women in Iraqi women as controls; at medical city in teaching Oncology hospital,70 breast cancer patients women their ages ranged (47.51 ± 1.18) and 20 healthy women with age (44.45 ± 2.66) begun from September (2020) to February (2021)...
May 2, 2024: Cytokine
https://read.qxmd.com/read/38700128/severe-heart-failure-and-intracardiac-thrombosis-going-beyond-the-appearance-for-diagnosis-and-treatments
#32
JOURNAL ARTICLE
Andrea Segreti, Sara Mastroberardino, Lorenzo Frau, Alessandro Appetecchia, Luca D'Antonio, Danilo Ricciardi, Gian Paolo Ussia, Francesco Grigioni
We describe the case of a 45-year-old female affected by asthma and nasal polyposis who presented to the emergency department because of worsening dyspnea and paresthesia of the left lower limb. Comprehensive instrumental examinations revealed the presence of severe left ventricle dysfunction, intra-cardiac thrombus, deep vein thrombosis, pulmonary embolism, lung infiltrates, polyserositis, and neurological involvements. Finally, the patient was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA), formerly Churg-Strauss syndrome, a rare vasculitis of small-medium blood vessels with several organ involvements...
May 2, 2024: Monaldi Archives for Chest Disease
https://read.qxmd.com/read/38698975/cerebral-large-vessels-vasculitis-following-guillain-barr%C3%A3-syndrome-as-first-clinical-manifestations-of-primary-sjogren-s-syndrome-a-case-based-review
#33
Zakaria Saied, Rania Zouari, Amine Rachdi, Fatma Nabli, Dina Ben Mohamed, Samia Ben Sassi
BACKGROUND: Primary Sjogren's syndrome (pSS) is an autoimmune exocrinopathy in which extraglandular signs of pSS are determinant for the prognosis. Involvement of both peripheral and central nervous system (CNS) are known to be among the sites of high systemic activity in pSS. CASE PRESENTATION: We, herein, report a case of a 57-year-old female patient with pSS presenting with typical Guillan-Barré syndrome (GBS), shortly followed by acute headaches accompanied by cortical blindness...
May 15, 2024: Heliyon
https://read.qxmd.com/read/38695605/daratumumab-and-antineoplastic-therapy-versus-antineoplastic-therapy-only-for-adults-with-newly-diagnosed-multiple-myeloma-ineligible-for-transplant
#34
REVIEW
Peter Langer, Lukas John, Ina Monsef, Christof Scheid, Vanessa Piechotta, Nicole Skoetz
BACKGROUND: Multiple myeloma (MM) is a haematological malignancy that is characterised by proliferation of malignant plasma cells in the bone marrow. For adults ineligible to receive high-dose chemotherapy and autologous stem cell transplant, the recommended treatment combinations in first-line therapy generally consist of combinations of alkylating agents, immunomodulatory drugs, and proteasome inhibitors. Daratumumab is a CD38-targeting, human IgG1k monoclonal antibody recently developed and approved for the treatment of people diagnosed with MM...
May 2, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38694785/ewing-sarcoma-of-the-pancreas-a-pediatric-case-report-and-narrative-literature-review
#35
Zhensheng Liu, Jian Bian, Yong Yang, Decheng Wei, Shiqin Qi
Ewing's Sarcoma (ES) is an rare, small round-cell sarcoma that predominantly occurs in children and young adults, with both skeletal and extraskeletal manifestations. However, pancreatic ES, due to its rarity, is infrequently featured in scholarly literature, with only a scant 43 reported instances. Our study describes a case of pancreatic ES in an 8-year-old boy who was found to have an abdominal mass. Following an exhaustive examination, the boy was diagnosed with a neoplasm in the pancreatic head and underwent a complex surgical procedure encompassing pancreatoduodenectomy and partial transverse colectomy...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38694660/frequency-of-complete-remission-with-r-chop-therapy-in-patients-with-diffuse-large-b-cell-lymphoma
#36
JOURNAL ARTICLE
Sani U Hassan, Shah Hussain, Mahnoor Fakhar, Azaz Ahmad, Fakeeda Durrani
Background Diffuse large B-cell lymphoma (DLBCL) exhibits notable heterogeneity in clinical presentations and treatment responses, posing challenges in predicting outcomes and tailoring therapeutic strategies for affected patients. Despite advancements in molecular subtyping and prognostic assessment, uncertainties persist regarding the optimal management of DLBCL, highlighting the need for localized investigations to better understand treatment responses and outcomes within specific patient populations. Objective To assess the frequency of complete remission (CR) in diffuse large B-cell lymphoma (DLBCL) patients undergoing first-line rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy within a specific adult population...
April 2024: Curēus
https://read.qxmd.com/read/38694384/brentuximab-induced-pneumonitis-and-organizing-pneumonia-a-case-report-with-literiture-review
#37
Omar R S Khalil, Shatha M A Mallah, Fahed Owda, Hamza Salim, Haneen Mallah, Jehad Azar
INTRODUCTION AND IMPORTANCE: Brentuximab vedotin (BV) is an anti-CD30 antibody approved for various cancers, including refractory Hodgkin lymphoma (HL), anaplastic large-cell lymphoma (ALCL) among others. In general, BV has been found to be well-tolerated, with the most frequently reported side effects being peripheral neuropathy and neutropenia. BV-induced pneumonitis is extremely rare. To the best of our knowledge, this is the sixth reported instance of BV-induced lung toxicity. CASE PRESENTATION: This case presents a female patient in her forties diagnosed with cutaneous T-cell lymphoma undergoing BV treatment...
May 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38693677/fludarabine-cyclophosphamide-and-rituximab-as-first-line-treatment-in-patients-with-chronic-lymphocytic-leukemia-a-long-term-analysis-of-the-german-cll-study-group-gcllsg-registry
#38
JOURNAL ARTICLE
Nadine Kutsch, Adam Giza, Sandra Robrecht, Janina Stumpf, Anno Federhen, Andrea Stoltefuß, Ursula Vehling-Kaiser, Michael Koenigsmann, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Thomas Illmer, Rudolf Schlag, Steffen Dörfel, Tobias Gaska, Michael Kiehl, Sigrun Müller-Hagen, Enno Moorahrend, Hartmut Linde, Anke Schlenska-Lange, Julia von Tresckow, Kirsten Fischer, Barbara Eichhorst, Michael Hallek, Anna Maria Fink
Long-term data of chronic lymphocytic leukemia (CLL) patients with favorable risk who were treated with fludarabine, cyclophosphamide, and rituximab (FCR) within clinical trials show good efficacy. We here report long-term data collected within the GCLLSG registry. Altogether, 417 CLL patients who received first-line treatment with FCR were analyzed, of which 293 (70.3%) were treated outside of clinical trials. The median observation time from first-line was 95.8 (interquartile range 58.7-126.8) months. Focusing on data of 194 (46...
May 1, 2024: European Journal of Haematology
https://read.qxmd.com/read/38691651/lifileucel-amtagvi-a-cellular-therapy-for-melanoma
#39
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 29, 2024: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38689628/low-grade-myofibrosarcoma-of-the-maxillary-sinus-two-case-reports
#40
Anna Mydlak, Łukasz Ścibik, Monika Durzynska, Jakub Zwoliński, Karolina Buchajska, Olga Lenartowicz, Jakub Kucharz
BACKGROUND: Low-grade myofibroblastic sarcoma (LGMS) is an extremely rare tumor characterized by the malignant proliferation of myofibroblasts. LGMS most commonly develops in adults, predominantly in males, in the head and neck region, oral cavity, especially on the tongue, mandible, and larynx. This article presents 2 cases of LGMS localized to the maxillary sinus and provides an overview of the available literature. CASE SUMMARY: Two patients with LGMS located in the maxillary sinus underwent surgery at the Department of Head and Neck Surgery...
April 24, 2024: World Journal of Clinical Oncology
keyword
keyword
8444
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.